To view all additional 2016 news, click here
To view all additional 2015 news, click here
December 14, 2014
John Chae, MD, MS presents the use of percutaneous PNS in the treatment of low back pain at the 18 Annual Meeting of the North American Neuromodulation Society, Las Vegas, Nevada.
To view all additional 2014 news, click here
January 8, 2013
SPR Therapeutics Raises $5 Million Series A
To view all additional 2013 news, click here
October 3, 2012
SPR Therapeutics & NDI Medical Awarded $2.77 Million Grant
To view all additional 2012 news, click here
To view all additional 2011 news, click here
May 17, 2010
Phase II SBIR awarded to fund and advance the development of our Smartpatch PNS System
To view all additional 2010 news, click here
To view all additional 2009 news, click here
The following bibliography references SPR Therapeutics pain management system publications to date. Some of these publications may describe findings that are not contemplated by the currently FDA-cleared indications for use for the product. The intent of providing this bibliography is to inform physicians of research performed using the SPRINT(TM) PNS System. This information is not provided with the intent to promote the SPRINT System beyond its FDA-cleared indications for use, which are as follows: ‘The SPRINT Peripheral Nerve Stimulation (PNS) System is indicated for up to 30 days in the back and/or extremities for: i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; ii) Symptomatic relief of post-traumatic pain; and iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region.’
deBock MG, Wongsarnpigoon A, Saulino MF, Gilmore CA, Boggs JW. Do percutaneous open-coil PNS leads have lower infection rates compared to conventional leads and catheters? Neuromodulation 2015; 18: e42 doi: 10.1111/ner.12277
Wilson RD, Harris MA, Gunzler DD, Bennett ME, Chae J. Percutaneous peripheral nerve stimulation for chronic pain in subacromial impingement syndrome: a case series. Neuromodulation 2014 Dec;17(8):771-6 doi: 10.1111/ner.12152
Chae J, Wilson RD, Bennett ME, Lechman TE, Stager KW. Single-Lead Percutaneous Peripheral Nerve Stimulation for the Treatment of Hemiplegic Shoulder Pain: A Case Series. Pain Pract. 2013 Jan;13(1):59-67
Wilson RD, Bennett ME, Lechman TE, Stager KW, Chae J. Single-lead Percutaneous Peripheral Nerve Stimulation for the Treatment of Hemiplegic Shoulder Pain: A Case Report. Archives of Physical Medicine and Rehabilitation, Vol 92(5): 837-40, May 2011.
Chae J, Yu DT, Walker ME, et al. Intramuscular electrical stimulation for hemiplegic shoulder pain: a 12-month follow-up of a multiple-center, randomized clinical trial. Am J Phys Med Rehabil. Nov 2005;84(11):832-842.
Renzenbrink GJ, IJzerman MJ. Percutaneous neuromuscular electrical stimulation (P-NMES) for treating shoulder pain in chronic hemiplegia. Effects on shoulder pain and quality of life. Clinical Rehabilitation. 2004; 18:359-365.
Chae J, Yu D, Walker M. Percutaneous, intramuscular neuromuscular electrical stimulation for the treatment of shoulder subluxation and pain in chronic hemiplegia: a case report. Am J Phys Med Rehabil. Apr 2001;80(4):296-301.
Yu DT, Chae J, Walker ME, Fang ZP. Percutaneous intramuscular neuromuscular electric stimulation for the treatment of shoulder subluxation and pain in patients with chronic hemiplegia: a pilot study. Arch Phys Med Rehabil. 2001;82(1):20-25.
Yu DT, Chae J, Walker ME, Hart RL, Petroski GF. Comparing stimulation-induced pain during percutaneous (intramuscular) and transcutaneous neuromuscular electric stimulation for treating shoulder subluxation in hemiplegia. Arch Phys Med Rehabil. 2001;82(6):756-760.
Click image thumbnail to download full-size image.